DCPH - Deciphera Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

DCPH is currently covered by 7 analysts with an average potential upside of $15.01 (45.4%) from yesterday's end of day stock price of $12.94. Deciphera Pharmaceuticals activity chart has currently 58 price targets and 72 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.87% with an average time for these price targets to be met of 134.93 days.

Highest price target for DCPH is $22, Lowest price target is $8, average price target is $15.

Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 31-Oct-2023. First documented stock forecast 04-Jun-2018.

Currently, out of the existing stock ratings of DCPH - 5 which are a Hold (27.78%), 11 which are a Buy (61.11%), 2 which are a Sell (11.11%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

22

$9.06 (70.02%)

14

1 months 3 days ago

1/3 (33.33%)

$12.36 (55.74%)

11

Hold

1 months 3 days ago

0/3 (0%)

$30.39 (62.41%)

Hold

23

$10.06 (77.74%)

13

1 months 4 days ago

10/18 (55.56%)

$14.54 (46.65%)

237

Buy

25

$12.28 (96.54%)

25

3 months 24 days ago

3/8 (37.5%)

$13.97 (72.54%)

118

Buy

23

$10.06 (77.74%)

23

5 months 29 days ago

1/6 (16.67%)

$5.64 (26.73%)

34

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DCPH (Deciphera Pharmaceuticals) average time for price targets to be met?

On average it took 134.93 days on average for the stock forecasts to be realized with a an average price target met ratio 43.87

Which analyst has the current highest performing score on DCPH (Deciphera Pharmaceuticals) with a proven track record?

ARLINDA LEE

Which analyst has the most public recommendations on DCPH (Deciphera Pharmaceuticals)?

Arlinda Lee works at CANACCORD and has 0 price targets and 0 ratings on DCPH

Which analyst is the currently most bullish on DCPH (Deciphera Pharmaceuticals)?

Konstantinos Aprilakis with highest potential upside - $62.28

Which analyst is the currently most reserved on DCPH (Deciphera Pharmaceuticals)?

Peter Lawson with lowest potential downside - -$3.94

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart